REG - Helium One Global Ld - AIM Rule 17 and Schedule 2(g) Update

Helium One GlobalAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260320:nRST3974Xa&default-theme=true

RNS Number : 3974X  Helium One Global Ltd  20 March 2026

 

 

 

20 March 2026

 

Helium One Global Ltd

("Helium One" or the "Company")

 

AIM Rule 17 and Schedule 2(g) Update

 

Helium One Global (AIM: HE1), the primary helium explorer in Tanzania with a
50% working interest in the Galactica-Pegasus helium development project
in Colorado, USA ("the Galactica Project"), announces that the following
information is being disclosed pursuant to Rule 17 and Schedule 2(g) of the
AIM Rules for Companies.

Sarah Cope, a Director of Helium One Global Ltd, was appointed, and remains,
as a Non-Executive Director of Eneraqua Technologies plc ("Eneraqua"), which
is not connected to Helium One Global Ltd, on 19 August 2021. On 16 March
2026, Eneraqua appointed liquidators to undertake an insolvent Creditors
Voluntary Liquidation of Eneraqua.

 

 

 

 

For further information please visit the Company's
website: www.helium-one.com (http://www.helium-one.com/)

 

 

 Helium One Global Ltd                                         +44 20 7920 3150
 Lorna Blaisse, CEO

 Graham Jacobs, Finance and Commercial Director

 Panmure Liberum Limited (Nominated Adviser and Joint Broker)  +44 20 3100 2000

 Scott Mathieson

 Phoebe Bunce

 Zeus Capital Limited (Joint Broker)                           +44 20 3829 5000

 Simon Johnson

 Louisa Waddell

 Tavistock (Financial PR)                                      +44 20 7920 3150

 Nick Elwes

 Saskia Sizen

 

 

Notes to Editors

 

Helium One Global, the primary helium explorer in Tanzania with a 50% working
interest in the Galactica-Pegasus helium development project in Colorado,
USA. The Company holds helium licenses within two distinct helium project
areas, across two continents. With an expanding global footprint, the Company
has the potential to become a strategic player in resolving a
supply-constrained helium market.

 

The Company's flagship southern Rukwa Project is located within the
southern Rukwa Rift Basin in south-west Tanzania.  This project entering a
full appraisal and development stage following the success of the 2023/24
exploration drilling campaign, which proved a helium discovery at Itumbula
West-1 and, following an extended well test ("EWT"), successfully flowed 5.5%
helium continually to surface in Q3 2024.

 

Following the success of the EWT, the Company filed a Mining Licence ("ML")
application with the Tanzania Mining Commission in September 2024 and the
480km(2) ML was formally awarded to the Company in July 2025.

 

The Company also owns a 50% working interest in the Galactica-Pegasus helium
development project in Las Animas County, Colorado, USA. This project is
operated by Blue Star Helium Ltd (ASX: BNL) and successfully completed a six
well development drilling campaign in H1 2025. The completion of the
development programme is a key component of the broader Galactica-Pegasus
development strategy; aimed at progressing the helium and CO(2) discoveries
to near-term commercial production.

 

This programme has seen a systematic approach to developing the extensive
Lyons Formation reservoir. The programme has delivered encouraging results, in
line with expectations, consistently encountering good helium (up to 3.3% He)
and CO(2) concentrations in the target formation and demonstrating promising
flow potential. The initial Galactica wells were tied into first gas in Q4
2025, with further wells coming onstream in 2026 for both helium and CO(2)
production.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZGMFGLFGVZZ



            Copyright 2019 Regulatory News Service, all rights reserved